CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
OLOX
Olenox Industries Inc.
There isn't enough reported data to score OLOX yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
OLOX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Unavailable | |
| Unavailable |
OLOX's revenue is currently healthy, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | โ |
| Current | 24x | $605 | โ |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
OLOX PE Valuation
OLOX has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
OLOX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect OLOX's losses to shrink, with revenue declining.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over OLOX on earnings quality, reporting a profit while its opponent remains loss making.
OLOX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$325.33 | +$2,100.27 |
| Q1 2026 | -$623.02 | +$3,248.98 |
| Q4 2025 | -$867.22 | +$5,871.98 |
| Q3 2025 | -$1,414.17 | +$15,653.66 |
| Q2 2025 | -$2,425.60 | +$16,320.00 |
| Q1 2025 | -$3,872.00 | +$15,346.74 |
| Q4 2024 | -$6,739.20 | +$10,824.58 |
| Q3 2024 | -$17,067.83 | -$8,911.00 |
OLOX lost $325.33 per share over the past year, a smaller loss than the year before.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over OLOX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over OLOX on profitability, with a higher operating margin.
OLOX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.1M | +194% |
| Q1 2026 | $285.3K | -50% |
| Q4 2025 | $613.7K | -41% |
| Q3 2025 | $1.1M | -40% |
| Q2 2025 | $721.4K | -42% |
| Q1 2025 | $566.4K | -44% |
| Q4 2024 | $1M | -47% |
| Q3 2024 | $1.8M | -56% |
OLOX's revenue is recovering but still below its 2021 peak: $2M last quarter, up 194% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -139% | +373 points |
| Q1 2026 | -1011% | -687 points |
| Q4 2025 | -984% | -536 points |
| Q3 2025 | -239% | -111 points |
| Q2 2025 | -511% | -288 points |
| Q1 2025 | -323% | +73 points |
| Q4 2024 | -449% | +212 points |
| Q3 2024 | -128% | -53 points |
OLOX's operating margin was โ139% last quarter, up 373 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the stronger cash trend. Its trailing FCF is up 39% versus its history, compared with OLOX at up 11%.
OLOX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$4.2M | -$3.1M |
| Q4 2024 | -$1.1M | +$1.5M |
| Q3 2024 | -$3.7M | -$2.1M |
| Q2 2024 | -$3.7M | -$2M |
| Q1 2024 | -$955.7K | +$954.1K |
| Q4 2023 | -$2.5M | -$1.7M |
| Q3 2023 | -$1.6M | -$1.2M |
| Q2 2023 | -$1.7M | +$7.8M |
OLOX has burned cash in most quarters: โ$7M over the past year, against โ$11M the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
OLOX Net Leverage
OLOX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
OLOX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 2.3 | Oversold |
OLOX's weekly RSI is 33 (neutral) and its Stochastic is 2 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
OLOX PE vs Industrials Sector
OLOX has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over OLOX on trend strength, trading above more of its moving averages.
OLOX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.79 | 20% below |
| 20 week MA | $2.20 | 71% below |
| 50 week MA | $8.16 | 92% below |
| 100 week MA | $140.6 | 100% below |
| 200 week MA | $2,234.1 | 100% below |
OLOX is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over OLOX on returns for 2026, with the stronger performance.
OLOX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16,953.9 | $30,904.8 | +82% |
| 2021 | $30,904.8 | $13,202.1 | -57% |
| 2022 | $13,202.1 | $6,961.1 | -47% |
| 2023 | $6,961.1 | $6,028.8 | -13% |
| 2024 | $6,028.8 | $310.7 | -95% |
| 2025 | $310.7 | $22.5 | -93% |
| 2026 YTD | $22.5 | $0.63 | -97% |
OLOX has finished five years in a row lower, and it's down 97% so far in 2026.